Indiana University (IU) — Indianapolis, Indiana

Indiana University (IU) is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana University (IU) has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Mural Oncology, Inc, NeuMoDx Molecular, Inc., Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University (IU)?

Indiana University (IU) has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University (IU) conducted?

Indiana University (IU) has 5 clinical trials on record, with 3 currently active. Their work covers Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Indiana University (IU) accredited by Crixeo Health?

Yes — Indiana University (IU) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana University (IU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.